Syncona Portfolio Ltd is an investment fund managing more than $85.9 billion ran by Robert Hutchinson. There are currently 3 companies in Mr. Hutchinson’s portfolio. The largest investments include Autolus Therapeutics plc and Achilles Therapeutics Plc, together worth $83.3 billion.
As of 6th August 2024, Syncona Portfolio Ltd’s top holding is 21,346,829 shares of Autolus Therapeutics plc currently worth over $74.3 billion and making up 86.5% of the portfolio value.
Relative to the number of outstanding shares of Autolus Therapeutics plc, Syncona Portfolio Ltd owns less than approximately 0.1% of the company.
In addition, the fund holds 11,086,909 shares of Achilles Therapeutics Plc worth $9.04 billion.
The third-largest holding is Century Therapeutics worth $2.55 billion.
Currently, Syncona Portfolio Ltd's portfolio is worth at least $85.9 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Syncona Portfolio Ltd office and employees reside in St Peter Port, Guernsey, United Kingdom. According to the last 13-F report filed with the SEC, Robert Hutchinson serves as the Director at Syncona Portfolio Ltd.
In the most recent 13F filing, Syncona Portfolio Ltd revealed that it had opened a new position in Century Therapeutics and bought 1,000,771 shares worth $2.55 billion.
The two most similar investment funds to Syncona Portfolio Ltd are Members Capital Advisors Inc and Wavelength Capital Management. They manage $85.9 billion and $85.9 billion respectively.
Syncona Portfolio Ltd’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 86.5% of
the total portfolio value.
The fund focuses on investments in the United Kingdom as
33.3% of the portfolio companies
are based in the United Kingdom.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $135 million.
These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Autolus Therapeutics plc |
No change
21,346,829
|
$74,286,965,000 | 86.51% |
| Achilles Therapeutics Plc |
No change
11,086,909
|
$9,035,831,000 | 10.52% |
| Century Therapeutics |
Opened
1,000,771
|
$2,551,966,000 | 2.97% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||